Brucellosis is an endemic zoonosis in Syria, affecting large numbers of animals and there are an increasing number of cases in humans. The aim of this study is to investigate the in vitro efficacy of various traditional and new antibiotics against 89 Brucella isolates (isolated from domestic animals) collected from different Syrian regions. Minimum inhibitory concentrations (MICs) of seventeen antibiotics were determined.
INTRODUCTION
Brucella is a facultative intracellular pathogen, a family of small, nonmotile, gram-negative coccobacilli, that causes abortion in domestic animals (sheep, cattle, and goats), and a febrile illness ("undulant fever") in humans (8, 9) . In Syria, it affects a large number of animals and an increasing number of cases in humans. The last recommendation by the World Health Organization (WHO) for the treatment of human acute brucellosis in adults suggested 600 to 900 mg rifampicin and 200 mg doxycycline daily for a minimum of 6 weeks, or doxycycline for 6 weeks plus streptomycin for 2-3 weeks (4).
However, the relapse rates associated with doxycycline/ rifampicin and doxycycline/streptomycin regimens are 4.6-24% and 5-8%, respectively (27) .
The combination between the rifampicin and trimethoprim-sulfomethoxazole is the suggested regimen for children (3, 15, 16) . Triple-antibiotic combinations were found to be of value in some cases of brucellar endocarditis, meningitis, and spondylitis (2, 21, 31) . Fluoroquinolones are an alternative. Only in vitro observations exist for moxifloxacin and levofloxacin (19) , whereas various combinations that incorporate ciprofloxacin and ofloxacin have been tried clinically, yielding similar efficacy to that of the classic regimens (13) . Fluoroquinolones have good anti-brucellosis activity in vitro (1, 18, 25) 
MATERIALS AND METHODS

Microorganisms and growth conditions
Eighty nine brucella isolates were collected prospectively A well containing no antibiotics was also employed.
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Antibiotics against Brucella
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RESULTS
The
This finding agrees with previous reports (6, 7, 16, 30) .
In addition, doxycyline had a very good activity against all isolates, with a MIC range of 0.3-0.75 μg/ml in the coastal region; whereas, rifampicin showed a very low activity against almost all isolates. On the other hand, eleven isolates were totally resistant to rifampicin. This finding did not agree with that found by Turkmani et al. (29) . However, Baykam et al. (6) and Dimitrov et al. (10) found that 9.6% and 8% of the isolates were resistant to rifampicin in vitro, respectively.
Most studies that examined the use of quinolones against B. melitensis showed, generally, low MICs values; where the MIC 90 to the ofloxacin was 0.02-2.5 mg/l (11, 14, 17) ; to the levofloxacin 0.5 mg/l (17, 28) ; to the sparfloxacin 0.12-2 mg/l (11, 12, 26) ; to the ciprofloxacin 0.06-2 mg/l (7, 17, 19) ; and to the moxifloxacin 0.5-1 mg/l (19, 28) . However, among the quinolones that are used in our study, ciprofloxacin revealed the lowest MIC range against the isolates collected from all Syrian regions (MIC range 0.07-6.25 μg/ml), and moxifloxacin showed the highest MIC range (MIC range 1.5-100 μg/ml).
In conclusion, among the antibiotics used in this study, quinolones were the most effective agents against Syrian brucella isolates. Ciprofloxacin and ofloxacin showed a very good activity; sparfloxacin and levofloxacin were quite active, whereas, moxifloxacin had limited effects. Further and more specific studies, in vivo, are much recommended to determine the efficacy of quinolones in the treatment of brucellosis infections.
On the other hand, doxycycline and tetracycline had a quite good activity. Since rifampicin is commonly used for prevalent diseases such as tuberculosis, the regional susceptibility pattern of rifampicin should be assessed periodically.
Spiramycin, amoxicillin and cephalosporins were included in this study for research purposes only, as those agents are ineffective in vivo for brucellosis treatment.
